Skip to main content

Successful presentation of new C-RAD products at the annual AAPM meeting in the US

C-RAD AB with its three fully owned subsidiaries develops new and innovative
solutions for the use in advanced radiation therapy. The company attended and
exhibited at the AAPM annual meeting in Houston, TX, USA, July 27-30. US
customers showed strong interest both for the Sentinel system with new
functionality and in the announcement of the GEMini detector system for use in
radiation therapy. 

C-Rad has also received its first order for the GEMini system. An agreement has
been signed with a multinational producer of radiation therapy equipment. The
first system is planned for delivery in first quarter 2009. The agreement is
confidential. 

The annual meeting of the American Association of Physicists in Medicine (AAPM)
is one of the major events within the radiation therapy industry and was
concluded in Houston, TX, in July 27-30. C-RAD was present at the industrial
exhibition of AAPM with great success. 

The laser scanner system, SentinelTM, was demonstrated with full functionality
for patient positioning and the newly released motion detection functionality.
The combined positioning and motion detection functionality offers a
streamlined workflow for the radiation therapy clinic. The motion detection
functionality offers a new dimension of accuracy for inter fractional movements
during treatment.  Furthermore, a first prototype of the respiratory gating
module, which will allow for highly accurate therapeutic delivery during the
breathing cycle, was demonstrated. 

A first version of the detector system GeminiTM for use in radiation therapy
was for the first time demonstrated. The detector system with its unique
technology and outstanding performance was presented to both representatives of
all major companies working in radiation therapy and attendees of the
conference. 

C-RAD was approached by a number of clinics in the North American market. Two
of the most well known radiation therapy centers expressed an interest to start
evaluation of both Sentinel and GEMini. 

 

Erik Hedlund, CEO, C-RAD AB:

"The interest we recognized at the recent AAPM meeting confirms that the C-RAD
group now is established as a manufacturer in radiation therapy to secure
precision in dose delivery and a cost effective work flow in the clinic. 

US customers showed great interest for the new Sentinel functionalities. The
module for respiratory gating has a large potential in the US. 

The C-RAD staff was very excited to present the first GEMini system optimized
for use in radiation therapy. A first agreement to adapt GEMini ED to a linear
accelerator has been signed. An important mile stone of the C-RAD group has
been reached. 

 

For further information: 

Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se





            
        
file[2].pdf
Close Menu